IVVD - Invivyd Inc Year-over-year net earnings per share growth for the last 12 months

Graphic logo of Invivyd (IVVD)

Price action on GURU.Markets shows the relative change in quarterly EPS, where the -13.10 metric determines this level. The trend is based on the risks of falling demand due to virus mutations, which threatens revenue. However, a flexible antibody development platform mitigates competition, although uncertainty regarding government funding and pressure from industry behemoths create serious challenges for the stability of Invivyd, Inc. (IVVD).

invivyd.com (IVVD) Year-over-year net earnings per share change for the last twelve months: for the period 04/28/2023 - 11/12/2026

Comprehensive metric breakdowns and analytics for Invivyd, Inc. (IVVD)

- market value and analyst target forecast:
Price Chart invivyd.com|IVVD - Fair Value Consensus
- market capitalization statistics:
Market Valuation Invivyd Corp|IVVD - Enterprise Value
- book capitalization indicators:
Net Assets per Single Share Invivyd, Inc.|IVVD - Book Valuation of Business|Market Capitalization to Book Value Ratio invivyd.com|IVVD - Company Total Asset Base
- debt and liquidity data:
Debt to Equity Invivyd, Inc.|IVVD - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio invivyd.com|IVVD - Company Debts|Debts to Book Capitalization Invivyd Corp|IVVD - Long-Term Debt Volume|Company Current Liabilities Invivyd, Inc.|Quick Liquidity Indicator invivyd.com
- earnings and market multiples details:
IVVD - Company Net Income|Projected Future Earnings Invivyd, Inc.|IVVD - Price to Earnings Multiple|Projected Price to Earnings invivyd.com|IVVD - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Invivyd Corp|IVVD - Operating income before deduction of amortization|Earnings per share for the last twelve months Invivyd, Inc.|IVVD - Earnings per share for the last 12 months|Quarterly EPS earnings growth invivyd.com|IVVD - Net earnings per share growth this year|Expected earnings per share growth for next year Invivyd, Inc.
Fundamental valuation:Invivyd Inc - IVVD
Manufactured product of Invivyd

Fundamental asset screening begins by filtering for profit generation efficiency. This indicator measures the percentage change in net earnings per share per quarter, stripping market noise from the data. By analyzing the quarterly EPS growth vector, an investor determines the pace of business capitalization. For Invivyd, Inc. (IVVD), this trend reflects the commercial return on the development of adaptive antibodies. The growth of this metric confirms the successful implementation of innovative drugs targeting mutating viruses.

Competitors of Invivyd, Inc. (IVVD)

Gilead Sciences (GILD) - Year-over-year earnings per share growth for the last twelve months|Cidara Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months NVAX|Quarterly EPS earnings growth CureVac Pharma|Year-over-year earnings per share growth for the last twelve months Valneva SE (VALN)|Year-over-year net earnings per share change for the last twelve months vir.bio|Quarterly EPS earnings growth SIGA (SIGA Technologies)|Year-over-year net earnings per share change for the last twelve months Emergent BioSolutions Inc (EBS)|AVIR - Year-over-year earnings per share growth for the last twelve months|ENTA (Enanta Pharmaceuticals, Inc) - Year-over-year earnings per share growth for the last 12 months|INO (Inovio Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|HLVX (hillevax.com) - Year-over-year earnings per share growth for the last twelve months|KLRS (Kalaris Therapeutics) - Quarterly EPS earnings growth|Dyadic (DYAI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months NNVC (NanoViricides, Inc.)|Year-over-year earnings per share growth for the last twelve months TLPH (Talphera Corporation)|Cocrystal Pharma, Inc. - Year-over-year net earnings per share growth for the last 12 months|Traws Pharma Inc (TRAW) - Earnings per share growth in annualized terms for the last twelve months|Virios Therapeutics - Quarterly EPS earnings growth|QLGN (Qualigen Therapeutics Inc) - Year-over-year earnings per share growth for the last 12 months|ALVR (allovir.com) - Year-over-year net earnings per share growth for the last 12 months|VBI Vaccines - Year-over-year earnings per one share growth for the last 12 months|VIRI (Virios Therapeutics Inc.) - Quarterly EPS earnings growth|Vaxart Corp (VXRT) - Year-over-year net earnings per share change for the last twelve months